Cofounded by Justin Beck, Cultivation Technologies, Inc., provides infrastructure, manufacturing, technology, genetics, and branding to the legal medical cannabis industry. Headquartered in Irvine, California, Cultivation Technologies, Inc. (CTI), is the owner of the Coachella™ Premium cannabis concentrate and vape cartridges brand. On June 4, 2018, CTI announced that Coachella™ Premium was expanding its presence across California. The expansion will see Coachella™ Premium products featured in 10 locations across the state, including in such premier dispensaries as Connected Cannabis, Lighthouse, 420 Central, and From the Earth. Coachella™ Premium acquires craft cannabis from licensed cultivators and uses it to produce high-quality concentrates. With this craft cannabis, production artists create new formulations using advanced technologies available at Coachella Manufacturing. The finished creations undergo rigorous testing and scoring, after which only a few are selected to go to market. Coachella™ Premium products go through full panel testing, a quality that differentiates them from other concentrates in the market that do not go through the same analysis. The Coachella™ Premium brand features all major concentrates, including sauce, shatter, diamonds, sugar, and batter. Coachella™ Premium vape cartridges include natural fruit and cannabis-derived terpenes.
Offering the legal medical cannabis community a combination of technology, genetics, and branding capacities, Cultivation Technologies, Inc., recently launched its Coachella™ Premium product. Led by Justin Beck, Cultivation Technologies, Inc., emphasizes an approach that is at the forefront of California’s medical Cannabis sector.Within a fast-evolving regulatory framework, the Marijuana Industry News reported in early 2018 that the California Insurance Commissioner has announced the creation of the state’s first ever California cannabis surety bond program. This initiative reflects a mandate to provide state-legal cannabis companies with the type of commercial insurance coverage needed to support stable business growth. For a majority of businesses applying for licenses within the Medicinal and Adult-Use Cannabis Regulation and Safety Act, a $5,000 cannabis surety bond is required as a way of demonstrating that operations are in compliance with the cannabis business licensing authority. Included as part of this is a guarantee that compliance violation fines will be paid. Continental Heritage Insurance Company was approved as the first insurer statewide, able to provide such a cannabis surety bond product.
The Irvine, California firm, Cultivation Technologies, Inc., provides infrastructure, genetics, technology, and branding to the legal medical cannabis industry. With guidance from co-founder and Chief Strategy Officer Justin Beck, Cultivation Technologies, Inc., endeavors through the cannabis industry’s complex regulatory environment. Cultivation Technologies, Inc. reached a milestone with the announcement on June 7, 2018, that it achieved cumulative revenue of $1 million since initiating commercial operations in January 2018. The firm is highly encouraged with its revenue growth in just a few months since the start of operations. It will leverage this momentum for continued growth in the years ahead. Cultivation Technologies Inc.’s Coachella™ Premium brand of vape cartridges and cannabis concentrates has expanded its presence in various dispensaries across California. The brand’s product offering includes all the major concentrate types such as sugar, diamonds, batters, sauces, and shatter. The company’s interim extraction facility, located on its campus in Coachella, can process around 6,000 pounds of biomass monthly. The facility can be further expanded for additional production capacity.
Cultivation Technologies, Inc., was founded in 2015 by entrepreneurs Justin Beck and Rick Probst. Driven by a commitment to develop premium medical-grade cannabis products, Cultivation Technologies, Inc., provides infrastructure, genetics, branding, and technology to the legal cannabis industry. Research indicates that medical cannabis may offer multiple benefits, as explored below. 1. Pain management. Cannabis contains an active chemical known as tetrahydrocannabinol (THC), which possesses pain-relieving properties. Studies suggest that the THC in cannabis can help manage a wide variety of pain, such as chronic and neuropathic pain. One survey published in The Spine Journal reported that one in five patients at the Colorado Spine Center used cannabis to manage pain. 2. Decrease in anxiety. The cannabis plant also contains the active compound cannabidiol (CBD). Research suggests that CBD can positively impact the brain in low doses without triggering intoxication or euphoria. 3. Seizure reduction. Some clinical trials indicate that CBD may effectively reduce the occurrence of seizures in patients with severe epilepsy. In one large-scale trial, as published in the New England Journal of Medicine, nearly 40 percent of participants in the study experienced fewer seizures. 4. Inhibition of Alzheimer’s. Scientific studies show that THC may slow the progression of Alzheimer’s disease by interfering with the production of amyloid plaques, which destroy brain cells.
